- Citations, last 5 years
- 874
- Works, last 5 years
- 70
- h-index
- 61
- Scientists listed
- 8
- Grants since 2016
- 4
Grants received
2025–2027 · research · R44
AAV-mediated delivery of the inflammasome adapter protein, ASC, as a pro-apoptotic gene therapy for schwannoma
Na Nora Yang · Mersana Therapeutics (United States) · funded by National Institutes of Health
2024–2025 · research · R41
Development of a Novel AAV9 Gene Replacement Therapy for Neurofibromatosis Type 2
Nicole Henwood · Mersana Therapeutics (United States) · funded by National Institutes of Health
2024–2025 · research · R43
Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation
Adam Rocker · Mersana Therapeutics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing
Adam Rocker · Mersana Therapeutics (United States) · funded by National Institutes of Health